Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Lantheus Holdings (LNTH)
Lantheus Holdings (LNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,693,551
  • Shares Outstanding, K 68,489
  • Annual Sales, $ 935,060 K
  • Annual Income, $ 28,070 K
  • 60-Month Beta 0.66
  • Price/Sales 5.31
  • Price/Cash Flow 15.36
  • Price/Book 7.12
Trade LNTH with:

Options Overview Details

View History
  • Implied Volatility 71.73% ( -4.88%)
  • Historical Volatility 52.40%
  • IV Percentile 94%
  • IV Rank 76.92%
  • IV High 82.75% on 10/30/23
  • IV Low 35.03% on 06/08/23
  • Put/Call Vol Ratio 2.77
  • Today's Volume 1,749
  • Volume Avg (30-Day) 3,568
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 55,569
  • Open Int (30-Day) 39,454

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 1.20
  • Number of Estimates 6
  • High Estimate 1.23
  • Low Estimate 1.15
  • Prior Year 1.28
  • Growth Rate Est. (year over year) -6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.61 +16.95%
on 11/09/23
76.85 -6.24%
on 12/04/23
+8.65 (+13.63%)
since 11/08/23
3-Month
59.85 +20.39%
on 09/22/23
76.99 -6.41%
on 10/17/23
+5.65 (+8.52%)
since 09/08/23
52-Week
47.46 +51.82%
on 01/09/23
100.85 -28.55%
on 05/12/23
+18.55 (+34.66%)
since 12/08/22

Most Recent Stories

More News
Lantheus Holdings: Q3 Earnings Snapshot

Lantheus Holdings: Q3 Earnings Snapshot

LNTH : 72.50 (+5.79%)
Why Shares of Point Biopharma Global Are Soaring Tuesday

The company entered into a buyout agreement with Eli Lilly.

LNTH : 72.50 (+5.79%)
LLY : 595.39 (+1.21%)
PNT : 14.04 (+0.65%)
Lantheus Holdings: Q2 Earnings Snapshot

Lantheus Holdings: Q2 Earnings Snapshot

LNTH : 72.50 (+5.79%)
3 Medical Research Stocks to Buy This Week

With the increased demand for innovative medical products and services, the medical research industry is poised for robust growth. Therefore, three medical research stocks Laboratory Corporation of America...

LH : 216.23 (-0.64%)
LNTH : 72.50 (+5.79%)
PNT : 14.04 (+0.65%)
QGEN : 41.52 (-1.19%)
2 Medical Imaging Stocks That Are Better Buys Than Nano-X

Both companies are using artificial intelligence to improve their products.

GE : 120.55 (+0.90%)
NNOX : 6.02 (+2.21%)
GEHC : 67.83 (+0.65%)
LNTH : 72.50 (+5.79%)
2 Most Promising Biotech Stocks to Buy

Given the breakthrough developments and government initiatives, the biotech industry is well-positioned to grow steadily. Therefore, fundamentally strong biotech stocks Amicus Therapeutics (FOLD) and POINT...

FOLD : 11.25 (-1.92%)
LNTH : 72.50 (+5.79%)
PNT : 14.04 (+0.65%)
Lantheus Holdings, Inc. (LNTH) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Lantheus Holdings (LNTH). This makes it worthwhile to examine what the stock has in store.

LNTH : 72.50 (+5.79%)
Lantheus Holdings (LNTH) Crossed Above the 20-Day Moving Average: What That Means for Investors

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

LNTH : 72.50 (+5.79%)
Why Shares of Lantheus Holdings Are Up Thursday

The company reported a record quarter for revenue.

LNTH : 72.50 (+5.79%)
Lantheus Holdings (LNTH) Q1 Earnings and Revenues Surpass Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 13.95% and 7.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LNTH : 72.50 (+5.79%)
BLFS : 13.24 (+4.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations,...

See More

Key Turning Points

3rd Resistance Point 79.46
2nd Resistance Point 76.16
1st Resistance Point 72.34
Last Price 72.50
1st Support Level 65.22
2nd Support Level 61.92
3rd Support Level 58.10

See More

52-Week High 100.85
Fibonacci 61.8% 80.46
Fibonacci 50% 74.16
Last Price 72.50
Fibonacci 38.2% 67.86
52-Week Low 47.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar